Skip to main content
Andrew Lightfoot, MD, General Surgery, Davenport, IA

AndrewJLightfootMD

General Surgery Davenport, IA

Physician

Are you Dr. Lightfoot?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 39 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3319 Spring St
    Davenport, IA 52807
    Phone+1 563-359-1641
    Fax+1 563-359-4634

Summary

  • Dr. Andrew Lightfoot, MD is a general surgeon in Davenport, Iowa. He is currently licensed to practice medicine in Iowa, Illinois, and Pennsylvania. He is affiliated with Genesis Medical Center - Davenport.

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Urology, 2007 - 2013
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2007

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 2007 - 2026
  • IL State Medical License
    IL State Medical License 2014 - 2026
  • PA State Medical License
    PA State Medical License 2013 - 2014
  • American Board of Urology Urology

Publications & Presentations

PubMed

Press Mentions

  • Procarta Receives CARB-X Award of up to $9.2 Million
    Procarta Receives CARB-X Award of up to $9.2 MillionSeptember 17th, 2019
  • Procarta Raises €1.5 Million to Develop a New Class of Antibiotics to Combat Antimicrobial Resistance
    Procarta Raises €1.5 Million to Develop a New Class of Antibiotics to Combat Antimicrobial ResistanceMarch 5th, 2019
  • EU Referendum: Now Top Life Science Bosses Warn of Brexit Risk, Including GSK, AstraZeneca and Pfizer in Open Later
    EU Referendum: Now Top Life Science Bosses Warn of Brexit Risk, Including GSK, AstraZeneca and Pfizer in Open LaterMay 8th, 2016